Zomedica Pharmaceuticals Corp (CVE:ZOM)’s share price reached a new 52-week low during trading on Friday . The stock traded as low as C$0.39 and last traded at C$0.39, with a volume of 22500 shares. The stock had previously closed at C$0.43.
The stock has a market capitalization of $46.43 million and a P/E ratio of -1.52.
Zomedica Pharmaceuticals (CVE:ZOM) last released its quarterly earnings results on Tuesday, February 26th. The company reported C($0.12) EPS for the quarter.
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.
Featured Article: What is Considered a Good Return on Equity (ROE)?
Receive News & Ratings for Zomedica Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.